17th Dec 2015 09:22
LONDON (Alliance News) - Cyprotex PLC said Thursday its performance in the last quarter of 2015 has been ahead of expectations, and as a result, its full year earnings before interest, tax, depreciation and amortisation will "significantly exceed current market expectations".
Cyprotex provides preclinical services for the pharmaceutical, biotechnology, cosmetic, personal care, agrochemical, chemical industries and academia segments.
Shares in Cyprotex jumped 9.0% to 88.32 pence Thursday morning following the news, having traded up to a new 52-week high of 92.00p earlier.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
CRX.L